Back to Journals » OncoTargets and Therapy » Volume 13

miR-100 Inhibits Cell Growth and Proliferation by Targeting HOXA1 in Nasopharyngeal Carcinoma

Authors He W, Huang Y, Jiang C, Zhu Y, Wang L, Zhang W, Huang W, Zhou T, Tang S

Received 26 August 2019

Accepted for publication 21 November 2019

Published 20 January 2020 Volume 2020:13 Pages 593—602

DOI https://doi.org/10.2147/OTT.S228783

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Editor who approved publication: Dr Tohru Yamada


Weifeng He, 1,* Yun Huang, 2,* Cheng chuan Jiang, 1 Yuan Zhu, 3 Ling Wang, 4 Weiwei Zhang, 1 Weiguo Huang, 2 Ting Zhou, 1, 5 Sanyuan Tang 1

1Department of Oncology, Brain Hospital of Hunan Province, Changsha 410007, Hunan Province, People’s Republic of China; 2Cancer Research Institute, Hengyang Medical College of University of South China, Hengyang 421001, Hunan Province, People’s Republic of China; 3People’s Hospital of Changshou Chongqing, Chongqing 401220, People’s Republic of China; 4Yi Chang Central People’s Hospital, Yichang 443000, Hubei Province, People’s Republic of China; 5Department of Clinical Pharmacy, College of Pharmacy, Hunan University of Traditional Chinese Medicine, Changsha 410007, Hunan Province, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Sanyuan Tang
Department of Oncology, Brain Hospital of Hunan Province, Changsha, Hunan Province, People’s Republic of China
Tel +86 15273156823
Email tangsy09@126.com
Ting Zhou
Department of Oncology, Brain Hospital of Hunan Province, Changsha, Hunan Province, People’s Republic of China
Tel/Fax +86 18374819626
Email 964679474@qq.com

Background: Increasing evidence indicates that the dysregulation of miRNAs plays a vital role in tumorigenesis and progression of nasopharyngeal carcinoma (NPC). Thus, it is necessary to further investigate the function and mechanism of miRNAs in NPC.
Methods: miR-100 expression was analyzed using publicly available databases and then tested using quantitative RT-PCR in NPC tissues and cell lines. MTT and colony formation assays and xenograft tumor model were used to test the NPC cell growth and proliferation abilities while modulating miR-100 expression. The target of miR-100 was predicted with TargetScan and validated with luciferase reporter assay, quantitative RT-PCR, and Western blot.
Results: The expression of miR-100 was significantly reduced in NPC tissues and cell lines. Overexpression of miR-100 obviously suppressed NPC cell growth and proliferation, whereas silencing miR-100 promoted NPC cell growth and proliferation in vitro. HOXA1 (homeobox A1) was validated as a direct target of miR-100, and restoring HOXA1 expression could reverse the inhibitive effect of miR-100 on NPC cell growth and proliferation. The mRNA and protein expression of HOXA1 was increased in NPC cell lines. Furthermore, ectopic expression of miR-100 inhibited xenograft tumor growth in vivo.
Conclusion: Taken together, our findings suggest that miR-100 could suppress NPC growth and proliferation through targeting HOXA1, providing a novel target for the miRNA-mediated therapy for patients with NPC in the future.

Keywords: miR-100, nasopharyngeal carcinoma, proliferation, invasion, HOXA1

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]